New Millennium Group’s Elevance Health ELV Stock Holding History

New Millennium Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3	Closed	-$969	–	446
2025 Q3	$969	Sell	3 -3	-50%	-$933	﹤0.01%	351
2025 Q2	$2.43K	Sell	6 -3	-33%	-$1.21K	﹤0.01%	305
2025 Q1	$4.02K	Hold	9	–	–	﹤0.01%	286
2024 Q4	$3.4K	Hold	9	–	–	﹤0.01%	335
2024 Q3	$4.79K	Hold	9	–	–	﹤0.01%	228
2024 Q2	$4.99K	Buy	+9	New	+$4.76K	﹤0.01%	231
2024 Q1	–	Sell	-9	Closed	-$4.33K	–	164
2023 Q4	$4.33K	Hold	9	–	–	﹤0.01%	255
2023 Q3	$3.99K	Hold	9	–	–	﹤0.01%	227
2023 Q2	$4.07K	Hold	9	–	–	﹤0.01%	233
2023 Q1	$4.21K	Hold	9	–	–	﹤0.01%	249
2022 Q4	$4.69K	Buy	9 +6	+200%	+$3.05K	0.01%	249
2022 Q3	$1K	Hold	3	–	–	﹤0.01%	328
2022 Q2	$2K	Buy	+3	New	+$1.48K	﹤0.01%	285

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

New Millennium Group's ELV Position: Q4 2025 in Review

New Millennium Group sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 3 shares — an estimated $969 sold.

New Millennium Group first reported a position in ELV in Q2 2022 and held it in 13 quarters. The position peaked at $4.99K in Q2 2024. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

New Millennium Group reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
New Millennium Group sold 3 Elevance Health shares in Q4 2025, an estimated $969.
New Millennium Group first reported a position in Elevance Health in Q2 2022 and held it in 13 quarters.
New Millennium Group's Elevance Health position peaked at $4.99K in Q2 2024.
1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.